Clinical Trial Update: Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study

View source ↗

Summary

A completed proof-of-concept pilot study evaluated adherence to Cayston (aztreonam for inhalation) therapy in cystic fibrosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Cayston (aztreonam lysine)

Snippet

Sponsor: Landon Pediatric Foundation | Conditions: Cystic Fibrosis | Status: COMPLETED